MEDICAL PRODUCTS
Human Ultracell V IM
Human Ultracell V Oral
Human Citoplacell 3G
Revercell 3G
Cellorgane Multi-Complex 3G
Androcell 3G
Biofemin 3G
Bioenzym 3G
Celltox 3G
Mekenz H7 3G
Cellorgane Man
Cellorgane Woman
Formula 1 Skin & Muscle
Formula 2 Liver
Formula 3 Heart-Artery-Vein
Formula 4 Bone-Cartilage
Formula 5 Kidney - Nephrons
Formula 6 Lungs
Formula 7 Brain-Hypothalamus-Pituitary
Formula 8 Adrenal Gland
Formula 9 Thymus - Spleen
Formula 10 Pancreas
Formula 11 Esophagus-Stomach-Intestines
LOGGED IN
No one logged in.

Human Ultracell®

V

Cellular Regeneration

Problem

Over the years, the body's cell functionality is progressively reduced by the effects of free radicals, augmented by the poor quality of life and exposure to chemical and environmental pollution.
These destructive effects result in damage to the production capacity of energy, proteins and enzymes and lead to the accumulation of undesirable biological material into cells.
The damage could affect the cell DNA and lead to degenerative diseases and accelerated aging.

Solution

Induce a cell renewal process, which allows:

  • Recycling undesirable biological material accumulated in the cells (autophagy).
  • Mitochondria recovery to restore its energy production capability.
  • Normalizing the control functions of DNA transcription process, preventing the possibility of mutations.
  • Neutralize the effects of free radicals.

Composition

Each 750 mg lyophilized vial contains:
Opotherapic lyophilized mesenchymal cell extracts, Embryo, umbilical cord; Phosphatidylserine, Dihydro-alpha-lipoic acid, Propionyl arginate, Riboflavin, Thiamine, Isonicotinate, Hypericin, vinpocetine, pregnenolone, coenzyme Q10, essential enzymes and Mannitol.

Each 2 ml. 250mg solvent syringe contains:
Placenta cells, amino acid complex with L-glutamine, L-arginine, L-pyroglutamate, GABA, L-glycine, L-lysine, L-carnitine acetyl, selegiline hydrochloride, procaine KH3, enzyme complex Antioxidants: superoxide dismutase, glutathione peroxide, glutathione reductase, glutathione transferase and stabilizers.

Action Mechanisms

The coenzymes NAD high content, together with mitochondria proliferation inducers contribute almost immediately to increase cellular energy production, which allows cells to develop an autophagy process, a cell cleaning process to recycle the unusable biological material accumulated in their cytoplasm.

With the gradual recovery of the energy production capacity and the effects of growth factor stimulating cytokines, a cellular function normalization process begins, particularly its protein production machinery and its DNA transcription controls, to avoid mistakes leading to dangerous mutations.

Normalizing the protein production capacity, leads to increased muscle mass, increased collagen in the skin, joints, connective tissue, etc.

Furthermore it improves cognitive functions, memory, etc. and stimulates the immune system.

Pharmacokinetics and Pharmacodynamics

Ingested formula components arrive intact to intestinal villi, thanks to the protection of the enteric layer and from there go into the bloodstream to be selectively incorporated by the cells via various means of cellular transport, depending on the size of molecules such components. Large molecules are incorporated by endocytosis and the smaller molecules are incorporated by simple diffusion or diffusion provided by receptor proteins, as appropriate.

The useful parts of the cell extracts are recycled and used in cells. The parts that are not useful are eliminated and expelled outside the cell.

The incorporation of the various components to the corresponding cell tissues is facilitated by the empathy developed by Biocell Laboratories between these components and the receptor proteins on the cell membrane surface.

Treatment Frequency and Administration

Taking into account that as we age the body’s cells are further broken down our recommended treatment frequency has been established by age.

With time our metabolism slows and cell deterioration increases necessitating treatments to be administered at a more frequent rate.

Based on these scientific facts we have established the following treatment protocol:

Patients ages 30 – 45:  One (1) 1000 mg (2 ml) injection to be repeated yearly.
Patients ages 46 – 60: One (1) 1000 mg (2 ml) injection to be repeated every six months.
Patients ages 61 and above: One (1) 1000 mg (2 ml) injection to be repeated every four months.

As always we recommend these dosages as a preventive and regenerative treatment, and we acknowledge that patients’ needs will vary.
Therefore, we leave total discretion to the criteria of each doctor and his patient.

Contraindications:

  • Allergies to animal proteins
  • Allergy to any of its components
  • Pregnancy and lactation
  • Do not take a month before or a month after application of biological vaccines.

Adjuvant treatment with:

Bronchodilators

Aminophylline, Theophylline, Tiotropium, albuterol, levalbuterol
Antihistamines Loratadine, Desloratadine, cetirizine, levocetirizine
Antihypertensive and heart failure
  • Calcium antagonists: Nifedipine
  • ACE inhibitors: Enalapril, Captopril
  • ARB-II: losartan, candesartan
  • Beta-blockers: Atenolol, Metoprolol, Carvedilol, Bisoprolol
  • Thiazide diuretics: Hydrochlorothiazide, chlorthalidone, indapamide, xipamide, Ameride (thiazide & K+ saver)
Hypoglycemic
  • Biguanides: Metformin
  • Inhibitors of alpha-glucosidase: Acarbose
  • Sulfonylureas: glibenclamide, glimepiride, glyburide and Tolazamide
  • Injectable drugs (like GLP-1): Sitagliptin, Saxagliptin, and linagliptin
  • Meglitinides: Repaglinide, nateglinide
  • SGLT2 Inhibitors: Dapagliflozin
  • Thiazolidinediones: Pioglitazone
  • DPP IV inhibitors: Sitagliptin and vildagliptin
  • Injectable insulin
Diuretics
  • Loop diuretics: Furosemide, Amiloride
  • Thiazide and analogues: IDEM (above)
  • K + Savers: Spironolactone
  • Osmotic: Mannitol
Statins

Selective, competitive inhibitors of HMG-CoA reductase: atorvastatin, simvastatin, pravastatin

Coronary vasodilators
  • Antianginal: Calcium antagonists - Nifedipine
  • Competitive antagonist of beta 1 and beta 2 adrenergic receptors: Propranolol
Heart failure Digitalis: Digoxin
Venous insufficiency
  • Venotonic and vasculoprotective drugs: Diosmin, Hidrosmin, Horse Chestnut Seed
Alzheimer
  • Reversible inhibitor of the enzyme acetylcholinesterase: Donepezil, Galantamine
  • NMDA receptor antagonist: Memantine
  • Neurometabolic stimulator: Piracetam
  • Porcine-brain derived peptide preparation: Cerebrolysin
  • Cholinesterase inhibitors: Rivastigmine
Hormone Replacement Therapy Estrogen, Progesterone, Testosterone, Prasterone, Mesterolone, Fluoxymesterone
Chemotherapy
  • Methotrexate, actinomycin D, vincristine, ifosfamide, Raltitrexed, Bevacizumab, Irinotecan, oxaliplatin, cetuximab, capecitabine, carboplatin, tamoxifen, cisplatin, Megestrol
  • Gestonorone, Anastrozole, Paclitaxel, Vinorelbine, Trastuzumab, leuprorelin, Diethylstilbestrol, Nilutamide, epirubicin, among others
Antidepressants
  • Selective serotonin reuptake inhibitors (SSRI): paroxetine, sertraline, fluoxetine, citalopram, escitalopram
  • Serotonin–norepinephrine reuptake inhibitors (SNRIs): venlafaxine, duloxetine, Desvenlafaxine
  • NaSSA: Mirtazapine
  • Tricyclic: amitriptyline, clomipramine, imipramine
  • MAOIs: Moclobemide
  • Serotonin–norepinephrine reuptake inhibitor (SNRI): Reboxetine
  • Dopamine-norepinephrine reuptake inhibitor (DNRI): Bupropion
Osteoporosis Zoledronic acid, bisphosphonates: risedronate, alendronate
Arthritis, Osteoarthritis, Pain relievers and anti-inflammatory
  • NSAIDs: ketorolac, paracetamol, diclofenac, indomethacin, Etoricoxib, diclofenac, misoprostol, etc. Opioids: Tramadol, morphine, buprenorphine, etc. Neuromodulators: Pregabalin
  • Gabapentin, Duloxetine. Corticosteroids: Dexamethasone, hydrocortisone, methylprednisolone, etc.
  • Corticosteroids: Betamethasone, Prednisone
Osteoarthritis Chondroitin, Glucosamine
Anti-anemic Iron
Renal impairment Recombinant erythropoietin, Furosemide, Amino Acids
Erectile dysfunction (ED) cyclic GMP-specific phosphodiesterase type 5 (PDE5): Sildenafil
Immunomodulators Interferon alfa
Antibiotics Beta-lactams, aminoglycosides, cephalosporins, macrolides
Intestinal motility regulators Cisapride, metoclopramide, Trimebutine, Pinaverium
Antacids Omeprazole, famotidine, pantoprazole, ranitidine
Stool softeners Fiber, Sennosides, Docusate
Digestive enzymes Bromelain, papain, pepsin, trypsin, lipase, Pancreatin

Alpha-blockers

Tamsulosin, terazosin, doxazosin, alfuzosin

Who We Are

Biocell Ultravital™ researches and develops innovative, 100% natural, pharmaceutical-grade bioproducts, on an exclusive basis worldwide. These products optimise cell nutrition and energy, producing a preventative and curative action which, in addition to treating pre-symptoms and symptoms by means of cell renewal, refuels and corrects the cell structure of tissues and organs, preventing the appearance of the functional stress loads which give rise to poor cell formation, degenerative diseases, and their after-effects.

Policies

Product developed under pharmaceutical control according to European CE standards. Made in the EC by Biocell Laboratory France, licensed and authorized by Biocell Ultravital GmbH, Switzerland.

Privacy

This website is governed by applicable laws and government regulations. Please see our Privacy Policy.
Use of this site constitutes your consent to application of such laws and regulations.

© 2018 Biocell Ultravital